Piperidine analogs and conjugates of procainamide and NAPA
US5525474A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jan 31, 1994 |
| Grant date | Jun 11, 1996 |
| Priority date | — |
| Expiry date | Jan 31, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/815
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Novel derivatives of procainamide and N-acetylprocainamide (NAPA) are disclosed having the following formula: ##STR1## wherein: X=hydrogen or acetyl; PA1 n=1 to p where p=MW of Z/1000; PA1 Z=a poly(amino acid) or polysaccharide; and PA1 R3=a bond or ##STR2## wherein R2=an alkyl, cycloalkyl or aryl group having 2 to 10 carbon atoms. The derivatives include maleimide conjugates of proteins or poly(amino acids), enzymes, enzyme donor polypeptides and labeling substances. Novel activated hapten intermediates useful in the preparation of the conjugates and methods for synthesis of the hapten intermediates and derivatives are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.